Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT) is a Healthcare stock tracked by StreetAlpha. It last closed at $38.60 on Jul 6. IMVT reports earnings on Mon, Nov 9, 2026. Over the past 90 days StreetAlpha recorded 2 whale options trades in IMVT, 50% of them bullish and 50% bearish. In the past 30 days there were 1 dark pool print totaling $734K, the largest $734K.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 1 analyst who set a price target on IMVT in the past 90 days. The average target is $50.00, with a high of $50.00 and a low of $50.00, compared with the last close of $38.60.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 4 | JP Morgan | Maintained | Buy | $50 |
| Jun 30 | Citigroup | Maintained | Buy | $61 |
| May 26 | Guggenheim | Maintained | Buy | $62 |
| May 22 | Truist Securities | Maintained | Hold | $30 |
| May 21 | B of A Securities | Maintained | Buy | $43 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IMVT is in one of them and how their past IMVT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered IMVT in an article yet. Here's the latest on the wider market.